KEQU PE Ratio & Valuation,Is KEQU Overvalued

KEQU Relative Valuation

KEQU's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, KEQU is overvalued; if below, it's undervalued.

Historical Valuation

Kewaunee Scientific Corp (KEQU) is now in the Fair zone, suggesting that its current forward PE ratio of 17.52 is considered Fairly compared with the five-year average of 12.45. The fair price of Kewaunee Scientific Corp (KEQU) is between 18.07 to 43.05 according to relative valuation methord.

Relative Value

Fair Zone

18.07-43.05

Current Price：38.30

Fair

17.82

13.94

EV/EBITDA

Kewaunee Scientific Corp. (KEQU) has a current EV/EBITDA of 13.94. The 5-year average EV/EBITDA is 8.42. The thresholds are as follows: Strongly Undervalued below -0.45, Undervalued between -0.45 and 3.99, Fairly Valued between 12.86 and 3.99, Overvalued between 12.86 and 17.30, and Strongly Overvalued above 17.30. The current Forward EV/EBITDA of 13.94 falls within the Overvalued range.

21.77

EV/EBIT

Kewaunee Scientific Corp. (KEQU) has a current EV/EBIT of 21.77. The 5-year average EV/EBIT is 13.16. The thresholds are as follows: Strongly Undervalued below -0.70, Undervalued between -0.70 and 6.23, Fairly Valued between 20.09 and 6.23, Overvalued between 20.09 and 27.02, and Strongly Overvalued above 27.02. The current Forward EV/EBIT of 21.77 falls within the Overvalued range.

0.69

Kewaunee Scientific Corp. (KEQU) has a current PS of 0.69. The 5-year average PS is 0.48. The thresholds are as follows: Strongly Undervalued below -0.08, Undervalued between -0.08 and 0.20, Fairly Valued between 0.77 and 0.20, Overvalued between 0.77 and 1.05, and Strongly Overvalued above 1.05. The current Forward PS of 0.69 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Kewaunee Scientific Corp. (KEQU) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.

0.00

P/FCF

Kewaunee Scientific Corp. (KEQU) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.

Kewaunee Scientific Corp (KEQU) has a current Price-to-Book (P/B) ratio of 1.55. Compared to its 3-year average P/B ratio of 1.89 , the current P/B ratio is approximately -17.64% higher. Relative to its 5-year average P/B ratio of 1.56, the current P/B ratio is about -0.51% higher. Kewaunee Scientific Corp (KEQU) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 1.80%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -2.77% , the current FCF yield is about -100.00% lower.

1.58

P/B

Median3y

1.89

Median5y

1.56

4.66

FCF Yield

Median3y

1.80

Median5y

-2.77

Competitors Valuation Multiple

The average P/S ratio for KEQU's competitors is , providing a benchmark for relative valuation. Kewaunee Scientific Corp Corp (KEQU) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 46.75%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of KEQU decreased by 37.79% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 47.76M to 70.10M.

The secondary factor is the P/E Change, contributed -41.91%to the performance.

Overall, the performance of KEQU in the past 1 year is driven by Revenue Growth. Which is more sustainable.

46.75%

47.76M → 70.10M

Revenue Growth

-42.63%

6.31 → 3.62

Margin Expansion

-41.91%

16.82 → 9.77

P/E Change

-37.79%

61.87 → 38.49

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Kewaunee Scientific Corp (KEQU) currently overvalued or undervalued?

What is Kewaunee Scientific Corp (KEQU) fair value?

KEQU's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Kewaunee Scientific Corp (KEQU) is between 18.07 to 43.05 according to relative valuation methord.

How does KEQU's valuation metrics compare to the industry average?

What is the current P/B ratio for Kewaunee Scientific Corp (KEQU) as of Dec 17 2025?

As of Dec 17 2025, Kewaunee Scientific Corp (KEQU) has a P/B ratio of 1.55. This indicates that the market values KEQU at 1.55 times its book value.

What is the current FCF Yield for Kewaunee Scientific Corp (KEQU) as of Dec 17 2025?

As of Dec 17 2025, Kewaunee Scientific Corp (KEQU) has a FCF Yield of 0.00%. This means that for every dollar of Kewaunee Scientific Corp’s market capitalization, the company generates 0.00 cents in free cash flow.

What is the current Forward P/E ratio for Kewaunee Scientific Corp (KEQU) as of Dec 17 2025?

As of Dec 17 2025, Kewaunee Scientific Corp (KEQU) has a Forward P/E ratio of 17.52. This means the market is willing to pay $17.52 for every dollar of Kewaunee Scientific Corp’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Kewaunee Scientific Corp (KEQU) as of Dec 17 2025?

As of Dec 17 2025, Kewaunee Scientific Corp (KEQU) has a Forward P/S ratio of 0.00. This means the market is valuing KEQU at $0.00 for every dollar of expected revenue over the next 12 months.

KEQU Valuation